NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Forecast, Price & News $2.78 -0.06 (-2.11%) (As of 12:44 PM ET) Add Compare Share Share Today's Range$2.78▼$2.8550-Day Range$2.50▼$3.1952-Week Range$1.63▼$4.19Volume6,423 shsAverage Volume171,241 shsMarket Capitalization$16.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Yield10 Bioscience MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.95% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$999,999 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.84) to ($0.78) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.78 out of 5 starsConsumer Staples Sector104th out of 140 stocksAgricultural Production - Crops Industry9th out of 11 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Yield10 Bioscience. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.95% of the float of Yield10 Bioscience has been sold short.Short Interest Ratio / Days to CoverYield10 Bioscience has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yield10 Bioscience has recently decreased by 27.78%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldYield10 Bioscience does not currently pay a dividend.Dividend GrowthYield10 Bioscience does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YTEN. Previous Next 2.8 News and Social Media Coverage News SentimentYield10 Bioscience has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 1 news article for Yield10 Bioscience this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for YTEN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added Yield10 Bioscience to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yield10 Bioscience insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,999.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 5.30% of the stock of Yield10 Bioscience is held by insiders.Percentage Held by InstitutionsOnly 7.69% of the stock of Yield10 Bioscience is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Yield10 Bioscience are expected to grow in the coming year, from ($1.84) to ($0.78) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Yield10 Bioscience is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yield10 Bioscience is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioYield10 Bioscience has a P/B Ratio of 14.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Yield10 Bioscience (NASDAQ:YTEN) StockYield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.Read More Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address YTEN Stock News HeadlinesMay 29, 2023 | americanbankingnews.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Short Interest UpdateMay 16, 2023 | americanbankingnews.comHC Wainwright Weighs in on Yield10 Bioscience, Inc.'s Q2 2023 Earnings (NASDAQ:YTEN)June 2, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 15, 2023 | americanbankingnews.comReviewing Yield10 Bioscience (NASDAQ:YTEN) & Edible Garden (NASDAQ:EDBL)May 13, 2023 | americanbankingnews.comYield10 Bioscience, Inc. to Post FY2027 Earnings of $0.10 Per Share, HC Wainwright Forecasts (NASDAQ:YTEN)May 12, 2023 | insidermonkey.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q1 2023 Earnings Call TranscriptMay 12, 2023 | finanznachrichten.deYield10 Bioscience, Inc.: Yield10 Bioscience Announces First Quarter 2023 Financial ResultsMay 12, 2023 | msn.comHC Wainwright & Co. Reiterates Yield10 Bioscience (YTEN) Buy RecommendationJune 2, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. May 12, 2023 | markets.businessinsider.comMaxim Group Remains a Buy on Yield10 Bioscience (YTEN)May 11, 2023 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Yield10 Bioscience (YTEN)May 11, 2023 | americanbankingnews.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Purchases $999,998.60 in StockMay 10, 2023 | msn.comYield10 Bioscience: Q1 Earnings InsightsMay 10, 2023 | finance.yahoo.comYield10 Bioscience Announces First Quarter 2023 Financial ResultsMay 9, 2023 | msn.comYield10 Bioscience's Earnings OutlookMay 9, 2023 | americanbankingnews.comYield10 Bioscience (YTEN) Scheduled to Post Quarterly Earnings on WednesdayMay 8, 2023 | americanbankingnews.comAnalyzing Yield10 Bioscience (NASDAQ:YTEN) & Fresh Del Monte Produce (NYSE:FDP)May 5, 2023 | marketwatch.com8-K: YIELD10 BIOSCIENCE, INC.May 4, 2023 | finance.yahoo.comYield10 Bioscience to Announce First Quarter 2023 Financial Results and Host a Conference Call on Wednesday, May 10, 2023May 3, 2023 | finance.yahoo.comYield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private PlacementMay 2, 2023 | americanbankingnews.comAMAYA Global (OTCMKTS:AYAG) versus Yield10 Bioscience (NASDAQ:YTEN) Head-To-Head ComparisonMay 1, 2023 | marketwatch.comYield10 Bioscience Shares Rise 14% After Possible Investment By Marathon PetroleumMay 1, 2023 | tmcnet.comYield10 Bioscience and Marathon Petroleum Corporation Sign LOIMay 1, 2023 | msn.comYield10 Bioscience inks LOI for potential investment, offtake deal with MarathonApril 29, 2023 | americanbankingnews.comShort Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Drops By 13.6%April 23, 2023 | americanbankingnews.comYield10 Bioscience (NASDAQ:YTEN) Stock Crosses Above 200-Day Moving Average of $2.76April 2, 2023 | americanbankingnews.comFinancial Analysis: Origin Agritech (NASDAQ:SEED) & Yield10 Bioscience (NASDAQ:YTEN)See More Headlines YTEN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YTEN Company Calendar Last Earnings3/14/2023Today6/02/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Agricultural production - crops Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:YTEN CUSIPN/A CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees29Year Founded1992Profitability EPS (Most Recent Fiscal Year)($2.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,570,000.00 Net Margins-3,882.82% Pretax Margin-3,842.10% Return on Equity-243.41% Return on Assets-143.90% Debt Debt-to-Equity RatioN/A Current Ratio1.08 Quick Ratio1.08 Sales & Book Value Annual Sales$450,000.00 Price / Sales37.99 Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book14.95Miscellaneous Outstanding Shares6,020,000Free Float5,701,000Market Cap$17.10 million OptionableNot Optionable Beta1.81 Social Links Key ExecutivesOliver P. PeoplesPresident, Chief Executive Officer & DirectorCharles B. HaaserChief Accounting Officer, Treasurer & VP-FinanceKristi D. SnellChief Science Officer & Vice President-ResearchNicholas RenegarDirector-Business Analytics & OperationsLynne H. BrumSecretary, VP-Planning & CommunicationsKey CompetitorsOrigin AgritechNASDAQ:SEEDLocal BountiNYSE:LOCLS&W SeedNASDAQ:SANWBarfresh Food GroupNASDAQ:BRFHMoolec ScienceNASDAQ:MLECView All CompetitorsInsiders & InstitutionsGrand Wealth Management LLCBought 28,282 shares on 5/10/2023Ownership: 0.558%Jack W SchulerBought 335,570 shares on 5/5/2023Total: $999,998.60 ($2.98/share)Anthony J SinskeyBought 2,000 shares on 8/17/2022Total: $5,600.00 ($2.80/share)Anthony J SinskeyBought 2,000 shares on 8/15/2022Total: $5,540.00 ($2.77/share)View All Insider TransactionsView All Institutional Transactions YTEN Stock - Frequently Asked Questions How have YTEN shares performed in 2023? Yield10 Bioscience's stock was trading at $1.6695 at the beginning of the year. Since then, YTEN stock has increased by 70.1% and is now trading at $2.8399. View the best growth stocks for 2023 here. Are investors shorting Yield10 Bioscience? Yield10 Bioscience saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 78,000 shares, a drop of 27.8% from the April 30th total of 108,000 shares. Based on an average daily volume of 43,600 shares, the days-to-cover ratio is currently 1.8 days. Currently, 2.0% of the shares of the company are short sold. View Yield10 Bioscience's Short Interest. When is Yield10 Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our YTEN earnings forecast. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its earnings results on Tuesday, March, 14th. The specialty chemicals company reported ($0.67) earnings per share for the quarter. The specialty chemicals company earned $0.09 million during the quarter. Yield10 Bioscience had a negative trailing twelve-month return on equity of 243.41% and a negative net margin of 3,882.82%. When did Yield10 Bioscience's stock split? Yield10 Bioscience's stock reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD). What is Yield10 Bioscience's stock symbol? Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN." Who are Yield10 Bioscience's major shareholders? Yield10 Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional investors include Grand Wealth Management LLC (0.56%). Insiders that own company stock include Anthony J Sinskey, Charles B Haaser and Jack W Schuler. View institutional ownership trends. How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Yield10 Bioscience's stock price today? One share of YTEN stock can currently be purchased for approximately $2.84. How much money does Yield10 Bioscience make? Yield10 Bioscience (NASDAQ:YTEN) has a market capitalization of $17.10 million and generates $450,000.00 in revenue each year. The specialty chemicals company earns $-13,570,000.00 in net income (profit) each year or ($2.84) on an earnings per share basis. How can I contact Yield10 Bioscience? Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The official website for the company is www.yield10bio.com. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at brets@coreir.com, or via fax at 617-583-1768. This page (NASDAQ:YTEN) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.